IL63541A - 5-(1-substituted sulfonamidoalkyl)indole-3-alkanamines,their preparation and pharmaceutical compositions containing them - Google Patents

5-(1-substituted sulfonamidoalkyl)indole-3-alkanamines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL63541A
IL63541A IL63541A IL6354181A IL63541A IL 63541 A IL63541 A IL 63541A IL 63541 A IL63541 A IL 63541A IL 6354181 A IL6354181 A IL 6354181A IL 63541 A IL63541 A IL 63541A
Authority
IL
Israel
Prior art keywords
alkanamines
sulfonamidoalkyl
indole
substituted
preparation
Prior art date
Application number
IL63541A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL63541A publication Critical patent/IL63541A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL63541A 1980-08-12 1981-08-11 5-(1-substituted sulfonamidoalkyl)indole-3-alkanamines,their preparation and pharmaceutical compositions containing them IL63541A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026288 1980-08-12

Publications (1)

Publication Number Publication Date
IL63541A true IL63541A (en) 1985-08-30

Family

ID=10515412

Family Applications (1)

Application Number Title Priority Date Filing Date
IL63541A IL63541A (en) 1980-08-12 1981-08-11 5-(1-substituted sulfonamidoalkyl)indole-3-alkanamines,their preparation and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (2) US4672067A (ru)
JP (1) JPS5759864A (ru)
AR (1) AR231533A1 (ru)
AT (1) AT381304B (ru)
AU (1) AU548270B2 (ru)
BE (1) BE889930A (ru)
CA (2) CA1169077A (ru)
CH (1) CH651550A5 (ru)
DE (1) DE3131748A1 (ru)
DK (1) DK157680C (ru)
ES (2) ES504695A0 (ru)
FI (1) FI812475L (ru)
FR (1) FR2488605A1 (ru)
GB (1) GB2081717B (ru)
GR (1) GR74536B (ru)
IE (1) IE51492B1 (ru)
IL (1) IL63541A (ru)
IT (1) IT1171451B (ru)
LU (1) LU83546A1 (ru)
MY (1) MY8600577A (ru)
NL (1) NL8103768A (ru)
NO (1) NO812722L (ru)
NZ (1) NZ197997A (ru)
PH (1) PH17428A (ru)
PT (1) PT73503B (ru)
SE (1) SE454881B (ru)
ZA (1) ZA815539B (ru)
ZW (1) ZW19381A1 (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79215B (ru) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
RU2160736C2 (ru) * 1990-06-07 2000-12-20 Зенека Лимитед Производные индола и их физиологически приемлемые соли и сольваты, способы их получения, лекарственное средство для лечения или профилактики клинических состояний, для которых показан прием агониста "5-нт1-подобного" рецептора, и способ его получения
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
EP0592438B1 (en) * 1990-10-15 1997-08-27 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
ES2033578B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.
ES2033577B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores.
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
JP2860603B2 (ja) * 1993-08-31 1999-02-24 ファイザー・インク． ５−アリールインドール誘導体
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5942536A (en) * 1995-10-10 1999-08-24 Eli Lilly And Company N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
WO2002083771A1 (fr) * 2001-04-13 2002-10-24 Organo Corporation Echangeur d'ions
KR20130136010A (ko) * 2005-04-13 2013-12-11 네우렉슨 인코포레이티드 Ｎｏｓ 저해 활성을 갖는 치환된 인돌 화합물
CA2991108A1 (en) 2015-07-02 2017-01-05 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870162A (en) * 1954-04-28 1959-01-20 Upjohn Co Production of certain tryptamines and compounds produced in the process
BE632051A (fr) * 1963-05-08 1963-11-18 Sandoz Sa Nouveaux dérivés de l'indole et leur préparation.
CH442303A (de) * 1964-06-26 1967-08-31 Sandoz Ag Verfahren zur Herstellung von neuen Indol-Derivaten
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4180509A (en) * 1977-07-01 1979-12-25 Merrell Toraude Et Compagnie α-Ethynyl tryptophanes
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
NZ197997A (en) 1985-08-16
ES8300700A1 (es) 1982-11-01
BE889930A (fr) 1982-02-11
ES8404327A1 (es) 1984-04-16
GB2081717A (en) 1982-02-24
US4636521A (en) 1987-01-13
ZW19381A1 (en) 1983-03-09
NO812722L (no) 1982-02-15
PT73503A (en) 1981-09-01
DE3131748A1 (de) 1982-04-01
ES513935A0 (es) 1984-04-16
SE8104782L (sv) 1982-02-13
AR231533A1 (es) 1984-12-28
DK357181A (da) 1982-02-13
LU83546A1 (fr) 1983-06-08
DK157680B (da) 1990-02-05
NL8103768A (nl) 1982-03-01
IT8149086A0 (it) 1981-08-11
DE3131748C2 (ru) 1992-04-23
AT381304B (de) 1986-09-25
IE51492B1 (en) 1987-01-07
IT1171451B (it) 1987-06-10
CA1169077A (en) 1984-06-12
FR2488605B1 (ru) 1984-11-16
ZA815539B (en) 1983-03-30
AU548270B2 (en) 1985-12-05
FI812475L (fi) 1982-02-13
IE811831L (en) 1982-02-12
SE454881B (sv) 1988-06-06
JPH0148895B2 (ru) 1989-10-20
GB2081717B (en) 1983-09-28
FR2488605A1 (fr) 1982-02-19
ATA352881A (de) 1986-02-15
GR74536B (ru) 1984-06-29
US4672067A (en) 1987-06-09
DK157680C (da) 1990-07-09
PH17428A (en) 1984-08-20
PT73503B (en) 1983-09-14
CA1169429A (en) 1984-06-19
MY8600577A (en) 1986-12-31
ES504695A0 (es) 1982-11-01
JPS5759864A (en) 1982-04-10
CH651550A5 (fr) 1985-09-30
AU7399681A (en) 1982-02-18

Similar Documents

Publication Publication Date Title
IL63541A (en) 5-(1-substituted sulfonamidoalkyl)indole-3-alkanamines,their preparation and pharmaceutical compositions containing them
IL63940A0 (en) Substituted imino-diacids,their preparation and pharmaceutical compositions containing them
IL63410A0 (en) Imidazole derivatives,their preparation and pharmaceutical compositions containing them
IL64256A0 (en) 2,4-diamino-(5-substituted)pyrimidines,their preparation and pharmaceutical compositions containing them
IL64665A (en) 4-amino-6,7-dimethoxy-2-piperazino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL64504A0 (en) Pyrimidones,their preparation and pharmaceutical compositions containing them
IL64444A0 (en) 8-arylalkyl-3-phenyl-3-nortropanols,their preparation and pharmaceutical compositions containing them
IL64388A0 (en) Imidazolylphenyl amidines,their preparation and pharmaceutical compositions containing them
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
ZA816844B (en) Substituted iminodiacids,their preparation and pharmaceutical compositions containing them
DE3169095D1 (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL62229A (en) 3-substituted-5-amino-1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
IL62495A0 (en) Pyrimidyl-quinazolines,their preparation and pharmaceutical compositions containing them
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
PH22546A (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL64555A0 (en) Pharmaceutical compositions containing 3-amine-2-pyrazoline derivatives,certain such novel derivatives and their preparation
IL62167A0 (en) Phenoxy-aminopropanol derivatives,their manufacture and pharmaceutical compositions containing them
IL63145A (en) Imidazothienopyrimidinedione derivatives,their manufacture and pharmaceutical compositions containing them
IL62592A0 (en) Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them
IL62970A0 (en) Substituted phenoxy-aminopropanol derivatives,their preparation and pharmaceutical compositions containing them
IL62606A0 (en) Pyrrolylpiperidines,their preparation and pharmaceutical compositions containing them
IL63174A0 (en) Dibenzindole derivatives,their preparation and pharmaceutical compositions containing them
IL63917A0 (en) 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them
IL61862A0 (en) 4,5-diaryl- -(polyhaloalkyl)-1h-imidazole-2-methanols,their preparation and pharmaceutical compositions containing them